The global immune repertoire sequencing market is expected to reach USD 209.7 million by 2028 at a CAGR of 8.4% during the forecast period. Profiling of T-and B-cell receptor repertoires in a private has led to a huge repository of data on immunity against various microorganisms. Next-generation immune repertoire sequencing has allowed researchers to form sophisticated immuno-bioinformatic analyses. It’s generated vast interest among the research community and biopharmaceutical industries within the clinical development of antibody engineering, vaccine design, and cellular immunotherapy. Rising applications of nutritional and intestinal immunology drive the rapid evolution of the next-generation immune repertoire sequencing. The innovative technology has provided unprecedented insight into host-microbiome immune homeostasis, and alongside single-cell transcriptomics holds great potential within the life sciences industries world over.
Immune Repertoire Sequencing Market Statistics (2017-2028)
Increasing support in terms of money from the domestic government regarding pharmacogenomics-based drug recovery is the primary factor for the growth in the demand for the product in the market. Also, the rapid growth in multiple therapeutic areas such as pain management, infectious diseases, cardiology, and oncology are further propelled the market growth of immune repertoire sequencing in the future.
Key Factors Impacting the Growth of Immune Repertoire Sequencing Market:
- Increase in government funding for pharmacogenomics-based drug recovery.
- The rapid growth in multiple therapeutic areas.
The immune repertoire sequencing market segmentation is based on component, application, end user, and region.
Immune Repertoire Sequencing Market Segmentation (2017-2028)
Component Outlook:
Based on components, the immune repertoire sequencing market is segmented into instrument, assay kits, software, and services. The instrument segment is going to dominate the market owing to the presence of leading players within the market are either offering platforms or software tools to integrate it into their solutions.
Application Outlook
Based on application, the immune repertoire sequencing market is segmented into biomarker discovery, autoimmune diseases, cancer immunotherapy, infectious disease research, asthma & allergy research, vaccine development, immunodeficiency identification, and others. The biomarker discovery segment is expected to dominate the market in 2018 and expected to dominate the market during the forecast period.
End User Outlook:
Based on the end user, the immune repertoire sequencing market is segmented into diagnostic labs, pharmaceutical & biotech companies, research institutes, and others. The diagnostic lab's segment is expected to grow at the highest CAGR during the forecast period owing to the increase in investment from the healthcare industries.
Regional Outlook:
Based on the region, the global Immune Repertoire Sequencing market has been segmented by North America, Western Europe, Eastern Europe, Asia Pacific, Middle East, & Rest of the World. In 2018, North America is predicted to dominate the market due to the growing demand for immunotherapy in the treatment of cancer and infectious diseases. Moreover, the developments in Europe from the domestic leading companies are expected to propel the market growth and growth in funding from the biomedical research and rising research in genomic and autoimmune disease are further enhance the demand in the domestic market over the forecast period.
Immune Repertoire Sequencing Market Regional Analysis (2017-2028)
Competitive Landscape
The leading companies in the immune repertoire sequencing market are focused on product development as well as the acquisition in the market to enhance the market share in the global market during the forecast period. This also expected to fuel market growth in the coming years. The key leading players in the global immune repertoire sequencing market include Adaptive Biotechnologies, Atreca, Inc., CD Genomics, Pacific Biosciences, Juno Therapeutics, Roche Holding AG, ArcherDX, Inc., and Illumina Inc.
This report also includes the profiles of key immune repertoire sequencing market companies along with their SWOT analysis and market strategies. In addition, these competitive landscapes provide a detailed description of each company including future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launch, new product developments, and other latest industrial developments.
Key Developments in Immune Repertoire Sequencing Market:
- In 2017, 10x Genomics Inc., U.S. based company, added B-Cell and 5’Unbiased Enrichment Kit to its chromium immune repertoire profiling solution or immune repertoire sequencing.
- In 2015, Illumina Inc. recalled its Illumina MiSeqDx Universal Kit 1.0, due to software limitations when using the product on MiSeqDx instrument.
Immune Repertoire Sequencing Market Timeline (2017-2028)
What Does This Report Provide?
This report provides a detailed understanding of the global immune repertoire sequencing market from qualitative and quantitative perspectives during the forecast period. The report also provides dynamic indicators with a potential impact on the market during the forecast period and an in-depth analysis of the leading companies operating in the immune repertoire sequencing market.
Market Segmentation:
Based on the Component
- Instrument
- Assay Kits
- Software
- Services
Based on the Application
- Biomarker Discovery
- Autoimmune Diseases
- Cancer Immunotherapy
- Infectious Disease Research
- Asthma and Allergy Research
- Vaccine Development
- Immunodeficiency Identification
- Others
Based on the End User
- Diagnostic Labs
- Pharmaceutical and Biotech Companies
- Research Institutes
- Others
By Region:
- North America
- By Country (US, Canada, Mexico)
- By Component
- By Application
- By End User
- Western Europe
- By Country (Germany, UK, France, Italy, Spain, Rest of Western Europe)
- By Component
- By Application
- By End User
- Eastern Europe
- By Country (Russia, Turkey, Rest of Eastern Europe)
- By Component
- By Application
- By End User
- Asia Pacific
- By Country (China, Japan, India, South Korea, Australia, Rest of Asia Pacific)
- By Component
- By Application
- By End User
- Middle East
- By Country (UAE, Saudi Arabia, Qatar, Iran, Rest of Middle East)
- By Component
- By Application
- By End User
- Rest of the World
- By Region (South America, Africa)
- By Component
- By Application
- By End User
Reasons to Buy This Report:
- Market size estimation of the immune repertoire sequencing market on a regional and global basis
- Unique research Usage for market size estimation and forecast
- Profiling of major companies operating in the immune repertoire sequencing market with key developments
- Broad scope to cover all the possible segments helping every stakeholder in the immune repertoire sequencing market
Customization:
We provide customization of the study to meet specific requirements:
- By Segment
- By Sub-segment
- By Region/Country
For more information, contact: sales@quincemarketinsights.com